Matthew Johnson is a Los Angeles, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Matthew Johnson is A196440 for Ophthalmology in California. Matthew Johnson is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Matthew Johnson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
1450 San Pablo St, Los Angeles, California, 90033-5331
Phone:
323-865-7785
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1356967863
NPI Enumeration Date:
20 Jun, 2020
NPI Last Update On:
20 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Matthew Johnson are as mentioned below.
License Number
Specialization
State
Status
A196440
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 31309, Los Angeles, California
Zip:
90031-0309
Phone Number:
626-457-6601
Fax Number:
--
Patients can reach Matthew Johnson at 1450 San Pablo St, Los Angeles, California or can call to book an appointment on 323-865-7785. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.